Oncovir
DC - WashingtonBiotechnology
Focus: Oncovir is a newly founded (2024) biotechnology company headquartered in Washington, DC focused on dsRNA viral mimics and gene therapy approaches to oncology and infectious diseases. The company operates as a pre-revenue biotech with an expansive pipeline of immunotherapy and vaccine candidates.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Open Jobs
0
About Oncovir
AI assessmentNot HiringNo open roles listed right now. Follow Oncovir to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
26 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1
CP 870,893
MelanomaClinical Trials (1)
Help build intelligence for Oncovir
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.